The Bird Flu is Back? Say it Ain’t So!

shutterstock_15283873

NPR reported that this dreaded disease, H5N1 or better known as "Bird Flu", is back and more virulent than ever.   If it was the same ole, same ole but on a different day, it wouldn't raise any alarm bells.  Tragically, however, it is a new strain, one that is not affected by any current vaccine. A flu virus of this nature resides low in the lungs and that is what makes it difficult for the body to rid itself of it.  Researchers have discovered that the Spanish flu of 1918 was a strain of … [Read more...]

What Immunocal can Do for Allergies and Lung Protection

Allergies and Lung Protection The risk of developing respiratory allergies from exposure to diesel emissions depends largely on genetics, according to a study funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Researchers from the Keck School of Medicine of the University of Southern California and the David Geffen School of Medicine at UCLA have found that genetic characteristics seen in about half the population leave … [Read more...]

Clinical Trial by US Government – Lung Cancer & Immunocal

Dr. Jimmy Gutman, MD

Immunotec Announces an Independent, Clinical Research Initiative at Beaumont Hospitals' Hospital's Community Clinical Oncology Program (CCOP). This Pilot Study is Supported by the Moffitt Cancer Center CCOP Research Base, which is funded by NCI. Posted : Sat, 01 Aug 2009 13:21:24 GMT Author : IMMUNOTEC INC. MONTREAL, Aug. 1 /PRNewswire-FirstCall/ - Immunotec Inc. (TSX-V: IMM) announced today that the U.S. Food and Drug Administration has approved an investigator-held IND (#105,140) for the … [Read more...]